Do analysts recommend TNON or SURG?

SurgePays has a consensus price target of $3.50, suggesting a potential upside of 973.62%. Given SurgePays' higher possible upside, analysts clearly believe SurgePays is more favorable than Tenon Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tenon Medical 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 SurgePays 2 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 1.67

Is TNON or SURG more profitable?

SurgePays has a net margin of -64.91% compared to Tenon Medical's net margin of -270.09%. SurgePays' return on equity of 0.00% beat Tenon Medical's return on equity. Company Net Margins Return on Equity Return on Assets Tenon Medical -270.09% -907.60% -110.17% SurgePays -64.91% N/A -310.16%

Does the media prefer TNON or SURG?

In the previous week, Tenon Medical and Tenon Medical both had 3 articles in the media. SurgePays' average media sentiment score of 1.87 beat Tenon Medical's score of 0.30 indicating that SurgePays is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tenon Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SurgePays 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Do analysts rate TNON or CODX?

Co-Diagnostics has a consensus price target of $67.50, suggesting a potential upside of 2,643.90%. Given Co-Diagnostics' higher possible upside, analysts plainly believe Co-Diagnostics is more favorable than Tenon Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tenon Medical 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Co-Diagnostics 1 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media refer more to TNON or CODX?

In the previous week, Tenon Medical had 1 more articles in the media than Co-Diagnostics. MarketBeat recorded 3 mentions for Tenon Medical and 2 mentions for Co-Diagnostics. Co-Diagnostics' average media sentiment score of 0.94 beat Tenon Medical's score of 0.30 indicating that Co-Diagnostics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tenon Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Co-Diagnostics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer QNRX or TNON?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Quoin Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Tenon Medical 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Do analysts prefer TNON or NXL?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tenon Medical 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Nexalin Technology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media refer more to TNON or NXL?

In the previous week, Tenon Medical had 1 more articles in the media than Nexalin Technology. MarketBeat recorded 3 mentions for Tenon Medical and 2 mentions for Nexalin Technology. Nexalin Technology's average media sentiment score of 1.89 beat Tenon Medical's score of 0.30 indicating that Nexalin Technology is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tenon Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Nexalin Technology 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Do analysts rate TNON or ALUR?

Allurion Technologies has a consensus target price of $45.00, indicating a potential upside of 7,658.62%. Given Allurion Technologies' higher possible upside, analysts plainly believe Allurion Technologies is more favorable than Tenon Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tenon Medical 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Allurion Technologies 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Tenon Medical (TNON) Competitors

$0.20 +0.00 (+0.10%)

As of 12:13 PM Eastern

Compare

TNON vs. SURG, CODX, QNRX, NXL, and ALUR

Should you buy Tenon Medical stock or one of its competitors? MarketBeat compares Tenon Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Tenon Medical include SurgePays (SURG), Co-Diagnostics (CODX), Quoin Pharmaceuticals (QNRX), Nexalin Technology (NXL), and Allurion Technologies (ALUR). These companies are all part of the "medical equipment" industry.

How does Tenon Medical compare to SurgePays?

Tenon Medical (NASDAQ:TNON) and SurgePays (NASDAQ:SURG) are both small-cap medical equipment companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, earnings, media sentiment, institutional ownership, profitability and dividends.

22.7% of Tenon Medical shares are held by institutional investors. Comparatively, 6.9% of SurgePays shares are held by institutional investors. 17.7% of Tenon Medical shares are held by company insiders. Comparatively, 29.1% of SurgePays shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

SurgePays has a net margin of -64.91% compared to Tenon Medical's net margin of -270.09%. SurgePays' return on equity of 0.00% beat Tenon Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tenon Medical	-270.09%	-907.60%	-110.17%
SurgePays	-64.91%	N/A	-310.16%

SurgePays has a consensus price target of $3.50, suggesting a potential upside of 973.62%. Given SurgePays' higher possible upside, analysts clearly believe SurgePays is more favorable than Tenon Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tenon Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
SurgePays	2 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.67

Tenon Medical has a beta of 1.36, meaning that its stock price is 36% more volatile than the broader market. Comparatively, SurgePays has a beta of 0.38, meaning that its stock price is 62% less volatile than the broader market.

Tenon Medical has higher earnings, but lower revenue than SurgePays. SurgePays is trading at a lower price-to-earnings ratio than Tenon Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tenon Medical	$4.60M	0.52	-$12.56M	-$1.29	N/A
SurgePays	$62.37M	0.13	-$36.07M	-$1.94	N/A

In the previous week, Tenon Medical and Tenon Medical both had 3 articles in the media. SurgePays' average media sentiment score of 1.87 beat Tenon Medical's score of 0.30 indicating that SurgePays is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Tenon Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
SurgePays	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Summary

Tenon Medical beats SurgePays on 8 of the 14 factors compared between the two stocks.

How does Tenon Medical compare to Co-Diagnostics?

Tenon Medical (NASDAQ:TNON) and Co-Diagnostics (NASDAQ:CODX) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, profitability, analyst recommendations, risk, dividends, earnings and valuation.

Tenon Medical has a beta of 1.36, meaning that its share price is 36% more volatile than the broader market. Comparatively, Co-Diagnostics has a beta of 2.84, meaning that its share price is 184% more volatile than the broader market.

22.7% of Tenon Medical shares are owned by institutional investors. Comparatively, 15.0% of Co-Diagnostics shares are owned by institutional investors. 17.7% of Tenon Medical shares are owned by insiders. Comparatively, 5.4% of Co-Diagnostics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Tenon Medical has higher revenue and earnings than Co-Diagnostics. Tenon Medical is trading at a lower price-to-earnings ratio than Co-Diagnostics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tenon Medical	$4.60M	0.52	-$12.56M	-$1.29	N/A
Co-Diagnostics	$620K	14.64	-$46.90M	-$15.77	N/A

Tenon Medical has a net margin of -270.09% compared to Co-Diagnostics' net margin of -6,760.63%. Co-Diagnostics' return on equity of -164.92% beat Tenon Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tenon Medical	-270.09%	-907.60%	-110.17%
Co-Diagnostics	-6,760.63%	-164.92%	-141.15%

Co-Diagnostics has a consensus price target of $67.50, suggesting a potential upside of 2,643.90%. Given Co-Diagnostics' higher possible upside, analysts plainly believe Co-Diagnostics is more favorable than Tenon Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tenon Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Co-Diagnostics	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, Tenon Medical had 1 more articles in the media than Co-Diagnostics. MarketBeat recorded 3 mentions for Tenon Medical and 2 mentions for Co-Diagnostics. Co-Diagnostics' average media sentiment score of 0.94 beat Tenon Medical's score of 0.30 indicating that Co-Diagnostics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Tenon Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Co-Diagnostics	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Tenon Medical beats Co-Diagnostics on 9 of the 14 factors compared between the two stocks.

How does Tenon Medical compare to Quoin Pharmaceuticals?

Quoin Pharmaceuticals (NASDAQ:QNRX) and Tenon Medical (NASDAQ:TNON) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, analyst recommendations, valuation, profitability, dividends, risk, media sentiment and institutional ownership.

Tenon Medical has higher revenue and earnings than Quoin Pharmaceuticals. Tenon Medical is trading at a lower price-to-earnings ratio than Quoin Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Quoin Pharmaceuticals	N/A	N/A	-$15.81M	-$29.56	N/A
Tenon Medical	$4.60M	0.52	-$12.56M	-$1.29	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Quoin Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Tenon Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Quoin Pharmaceuticals has a net margin of 0.00% compared to Tenon Medical's net margin of -270.09%. Quoin Pharmaceuticals' return on equity of -489.85% beat Tenon Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Quoin Pharmaceuticals	N/A	-489.85%	-221.29%
Tenon Medical	-270.09%	-907.60%	-110.17%

In the previous week, Tenon Medical had 1 more articles in the media than Quoin Pharmaceuticals. MarketBeat recorded 3 mentions for Tenon Medical and 2 mentions for Quoin Pharmaceuticals. Tenon Medical's average media sentiment score of 0.30 beat Quoin Pharmaceuticals' score of 0.22 indicating that Tenon Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
Quoin Pharmaceuticals	Neutral
Tenon Medical	Neutral

Quoin Pharmaceuticals has a beta of 1.52, meaning that its share price is 52% more volatile than the broader market. Comparatively, Tenon Medical has a beta of 1.36, meaning that its share price is 36% more volatile than the broader market.

8.6% of Quoin Pharmaceuticals shares are held by institutional investors. Comparatively, 22.7% of Tenon Medical shares are held by institutional investors. 13.5% of Quoin Pharmaceuticals shares are held by insiders. Comparatively, 17.7% of Tenon Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Tenon Medical beats Quoin Pharmaceuticals on 8 of the 12 factors compared between the two stocks.

How does Tenon Medical compare to Nexalin Technology?

Tenon Medical (NASDAQ:TNON) and Nexalin Technology (NASDAQ:NXL) are both small-cap medical equipment companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, profitability, earnings, dividends, media sentiment, valuation, risk and analyst recommendations.

22.7% of Tenon Medical shares are owned by institutional investors. Comparatively, 0.6% of Nexalin Technology shares are owned by institutional investors. 17.7% of Tenon Medical shares are owned by company insiders. Comparatively, 25.3% of Nexalin Technology shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Tenon Medical has a net margin of -270.09% compared to Nexalin Technology's net margin of -3,018.12%. Nexalin Technology's return on equity of -191.88% beat Tenon Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tenon Medical	-270.09%	-907.60%	-110.17%
Nexalin Technology	-3,018.12%	-191.88%	-166.43%

In the previous week, Tenon Medical had 1 more articles in the media than Nexalin Technology. MarketBeat recorded 3 mentions for Tenon Medical and 2 mentions for Nexalin Technology. Nexalin Technology's average media sentiment score of 1.89 beat Tenon Medical's score of 0.30 indicating that Nexalin Technology is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Tenon Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Nexalin Technology	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Tenon Medical has a beta of 1.36, suggesting that its stock price is 36% more volatile than the broader market. Comparatively, Nexalin Technology has a beta of 4, suggesting that its stock price is 300% more volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tenon Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Nexalin Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Nexalin Technology has lower revenue, but higher earnings than Tenon Medical. Nexalin Technology is trading at a lower price-to-earnings ratio than Tenon Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tenon Medical	$4.60M	0.52	-$12.56M	-$1.29	N/A
Nexalin Technology	$275.58K	35.94	-$8.22M	-$0.47	N/A

Summary

Tenon Medical beats Nexalin Technology on 8 of the 15 factors compared between the two stocks.

How does Tenon Medical compare to Allurion Technologies?

Tenon Medical (NASDAQ:TNON) and Allurion Technologies (NYSE:ALUR) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, valuation, analyst recommendations, profitability, media sentiment, earnings, dividends and institutional ownership.

Allurion Technologies has a net margin of -199.96% compared to Tenon Medical's net margin of -270.09%. Allurion Technologies' return on equity of 0.00% beat Tenon Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tenon Medical	-270.09%	-907.60%	-110.17%
Allurion Technologies	-199.96%	N/A	-77.13%

Allurion Technologies has higher revenue and earnings than Tenon Medical. Allurion Technologies is trading at a lower price-to-earnings ratio than Tenon Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tenon Medical	$4.60M	0.52	-$12.56M	-$1.29	N/A
Allurion Technologies	$17.21M	0.51	-$7.20M	-$2.03	N/A

Tenon Medical has a beta of 1.36, indicating that its share price is 36% more volatile than the broader market. Comparatively, Allurion Technologies has a beta of -0.13, indicating that its share price is 113% less volatile than the broader market.

22.7% of Tenon Medical shares are owned by institutional investors. Comparatively, 21.4% of Allurion Technologies shares are owned by institutional investors. 17.7% of Tenon Medical shares are owned by insiders. Comparatively, 8.1% of Allurion Technologies shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Allurion Technologies has a consensus target price of $45.00, indicating a potential upside of 7,658.62%. Given Allurion Technologies' higher possible upside, analysts plainly believe Allurion Technologies is more favorable than Tenon Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tenon Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Allurion Technologies	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, Tenon Medical had 3 more articles in the media than Allurion Technologies. MarketBeat recorded 3 mentions for Tenon Medical and 0 mentions for Allurion Technologies. Tenon Medical's average media sentiment score of 0.30 beat Allurion Technologies' score of 0.00 indicating that Tenon Medical is being referred to more favorably in the media.

Company	Overall Sentiment
Tenon Medical	Neutral
Allurion Technologies	Neutral

Summary

Tenon Medical and Allurion Technologies tied by winning 7 of the 14 factors compared between the two stocks.

Get Tenon Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TNON and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

TNON vs. The Competition

Export

Metric	Tenon Medical	MED INSTRUMENTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$2.38M	$7.53B	$6.87B	$12.58B
Dividend Yield	N/A	1.31%	2.68%	9.45%
P/E Ratio	-0.16	50.44	27.21	24.30
Price / Sales	0.52	91.90	516.66	87.93
Price / Cash	N/A	26.20	48.63	60.00
Price / Book	1.12	7.25	10.81	6.27
Net Income	-$12.56M	$162.30M	$3.59B	$331.55M
7 Day Performance	-12.36%	-0.39%	-2.12%	-1.53%
1 Month Performance	-66.52%	0.66%	3.24%	-0.59%
1 Year Performance	-80.20%	7.38%	26.02%	18.83%

Tenon Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
TNON Tenon Medical	0.6125 of 5 stars	$0.20 +0.1%	N/A	-80.2%	$2.38M	$4.60M	N/A	8
SURG SurgePays	4.4989 of 5 stars	$0.41 +0.7%	$3.50 +747.5%	-89.0%	$10.27M	$56.96M	N/A	40	News Coverage Positive News
CODX Co-Diagnostics	1.9958 of 5 stars	$2.59 -4.6%	$67.50 +2,511.2%	-68.9%	$9.54M	$620K	N/A	100	News Coverage Gap Down
QNRX Quoin Pharmaceuticals	0.6597 of 5 stars	$4.70 -2.1%	N/A	-52.1%	$9.45M	N/A	N/A	4	Gap Down
NXL Nexalin Technology	0.4273 of 5 stars	$0.43 +19.6%	N/A	-54.0%	$9.01M	$300K	N/A	3	News Coverage

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:TNON) was last updated on 7/16/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Tenon Medical (TNON) Competitors

TNON vs. SURG, CODX, QNRX, NXL, and ALUR

How does Tenon Medical compare to SurgePays?

Summary

How does Tenon Medical compare to Co-Diagnostics?

Summary

How does Tenon Medical compare to Quoin Pharmaceuticals?

Summary

How does Tenon Medical compare to Nexalin Technology?

Summary

How does Tenon Medical compare to Allurion Technologies?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TNON vs. The Competition

Tenon Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Tenon Medical (TNON) Competitors

TNON vs. SURG, CODX, QNRX, NXL, and ALUR

How does Tenon Medical compare to SurgePays?

Do insiders & institutionals believe in TNON or SURG?

Is TNON or SURG more profitable?

Do analysts recommend TNON or SURG?

Which has more risk and volatility, TNON or SURG?

Which has higher earnings & valuation, TNON or SURG?

Does the media prefer TNON or SURG?

Summary

How does Tenon Medical compare to Co-Diagnostics?

Which has more volatility & risk, TNON or CODX?

Do insiders and institutionals hold more shares of TNON or CODX?

Which has higher earnings & valuation, TNON or CODX?

Is TNON or CODX more profitable?

Do analysts rate TNON or CODX?

Does the media refer more to TNON or CODX?

Summary

How does Tenon Medical compare to Quoin Pharmaceuticals?

Which has stronger earnings and valuation, QNRX or TNON?

Do analysts prefer QNRX or TNON?

Is QNRX or TNON more profitable?

Does the media prefer QNRX or TNON?

Which has more volatility & risk, QNRX or TNON?

Do insiders & institutionals have more ownership in QNRX or TNON?

Summary

How does Tenon Medical compare to Nexalin Technology?

Do institutionals and insiders believe in TNON or NXL?

Is TNON or NXL more profitable?

Does the media refer more to TNON or NXL?

Which has more volatility & risk, TNON or NXL?

Do analysts prefer TNON or NXL?

Which has higher earnings & valuation, TNON or NXL?

Summary

How does Tenon Medical compare to Allurion Technologies?

Is TNON or ALUR more profitable?

Which has stronger earnings and valuation, TNON or ALUR?

Which has more risk and volatility, TNON or ALUR?

Do institutionals & insiders have more ownership in TNON or ALUR?

Do analysts rate TNON or ALUR?

Does the media refer more to TNON or ALUR?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TNON vs. The Competition

Tenon Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools